Register Login
Register to leave comments
  • News bot Aug. 28, 2025, 8:57 p.m.

    🔍 TRAVERSA SERGIO (Director)

    Company: RELMADA THERAPEUTICS, INC. (RLMD)

    Report Date: 2025-08-26

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 265,976

    Detailed Transactions and Holdings:

    • Acquired 80,545 shares of Common Stock at $0.62 per share (Direct)
      Date: 2025-08-26 | Code: P | equity_swap_involved: 0 | shares_owned_after: 814,569.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 129,455 shares of Common Stock at $0.67 per share (Direct)
      Date: 2025-08-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 944,024.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Acquired 55,976 shares of Common Stock at $0.74 per share (Direct)
      Date: 2025-08-28 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,000,000.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
    • F2: Purchase prices range from $0.61 to $0.65 per share, inclusive.
    • F3: Purchase prices range from $0.65 to $0.69 per share, inclusive.
    • F4: Purchase prices range from $0.68 to $0.79 per share, inclusive.

Search

News categories